You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 27 No. 1, July 1972 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Learned Behavior and Limbic System Activity in Experimental Porphyria

Henry Lesse, MD; Lennart Wetterberg, MD

Arch Gen Psychiatry. 1972;27(1):119-124.


Abstract

Allylisopropylacetamide (AIA), a porphyria-inducing compound, produces biochemical changes simulating those occurring in acute intermittent porphyria, an inborn error of metabolism characterized by neuropsychiatric symptoms. Little is known, however, about behavior or brain activity in experimental porphyria. Effects of AIA on performance of a discrimination task, on limbic system excitability, and on brain electroencephalographic activity were studied in cats. Small doses blocked learned reactions to environmental signals and to direct limbic system stimulation without impairing motility, sensory function, motivation, or level of arousal. Thresholds for evoking hippocampal after-discharges were markedly elevated. Additional behavioral aberrations and changes in brain electrical activity were induced by higher doses. Findings suggest that AIA decreases hippocampal excitability and interferes with ability to utilize certain signals which have acquired motivational significance during past learning experiences. This experimental model should prove helpful in studying neural and behavioral factors in the pathogenesis of acute porphyria.



Author Affiliations

Los Angeles

From the Neuropsychiatric Institute, Brain Research Institute, and the Department of Psychiatry, University of California, Los Angeles. Dr. Wetterberg was a USPHS International Postdoctoral Fellow and is currently with the Psychiatric Research Center, University of Uppsala, Ulleraker Hospital, Uppsala, Sweden.


Footnotes

Accepted for publication Jan 10, 1972.

Reprint requests to the Neuropsychiatric Institute, UCLA Center for the Health Sciences, 760 Westwood Plaza, Los Angeles 90024 (Dr. Lesse).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.